| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |